Department of Oncology, University Hospital J. Minjoz, Besancon, France.
Cancer J. 2009 Sep-Oct;15(5):361-5. doi: 10.1097/PPO.0b013e3181bd045f.
A main criterion to identify activity in phase II studies is the response rates achieved in a well-defined subset of patients. The response could be defined as a measure of tumor shrinkage. For 30 years, metric methods have been used to assess this response. The World Health Organization was the first organization to propose a unified definition for response status. Over time, the latter evolved and 10 years ago an international consensus panel proposed the Response Evaluation Criteria in Solid Tumors criteria. Although these guidelines for response assessment have limitations and biases, they have nevertheless been proven useful and advantageous. This article reviews those criteria and describes their use.
确定 II 期研究中活性的一个主要标准是在明确界定的患者亚组中实现的反应率。反应可以定义为肿瘤缩小的度量。三十年来,一直使用度量方法来评估这种反应。世界卫生组织是第一个提出反应状态统一定义的组织。随着时间的推移,后者不断发展,10 年前,一个国际共识小组提出了实体瘤反应评估标准。尽管这些反应评估指南存在局限性和偏见,但它们已被证明是有用和有利的。本文回顾了这些标准并描述了它们的用途。